AVANIR Pharmaceuticals Announces

Related by string. * Avanir : AVANIR Pharmaceuticals AMEX AVN . AVANIR Pharmaceuticals NASDAQ AVNR . Avanir Pharmaceuticals AVNR / pharmaceuticals . PHARMACEUTICALS . PHARMACEUTICAL : Barr Pharmaceuticals Inc. . Pharmaceutical Benefits Scheme . MAP Pharmaceuticals generates / announc ed . ANNOUNCES . ANNOUNCE : Announces Second Quarter . Announces Third Quarter . Announces Fourth Quarter * *

Related by context. Frequent words. (Click for all words.) 67 FDA Accepts 67 Generic Version 67 Presents Positive 66 Patient Enrollment 65 Drug Candidate 65 Patent Covering 64 FDA Clears 64 Achieves Milestone 64 Completes Enrollment 64 Announces Initiation 64 Receives Patent 64 FDA Clearance 63 Cholesterol Drug 63 Reduces Risk 63 Initiate Phase 62 Significantly Reduces 62 Receives Regulatory 62 Pivotal Phase III 62 Completes Tender Offer 62 Initiates Phase 62 Regains Compliance 62 Completes Initial 62 Phase III Clinical Trial 61 CHEAP ONLINE PHARMACY LOW 61 Extended Release 61 Receives FDA Clearance 61 Announces Shareholder Approval 60 Exclusive License 60 Pivotal Phase 60 Phase III Trial 60 Secures Additional 60 Secures Funding 60 Study Demonstrates 60 Receives Notice 60 Clinical Trial Results 60 Reports Positive 60 Announces Issuance 60 Preclinical Data 60 Completes Successful 60 Announces Definitive Agreement 59 Issues Guidance 59 FDA Approves 59 Small Molecule 59 Momentum Continues 59 Mechel Announces 59 Helps Prevent 59 Announces Termination 59 Recombinant Human 59 Cervical Cancer Vaccine 59 Positive Opinion 59 Provides Guidance 59 Announces Successful Completion 59 Closes Financing 59 FDA Orphan Drug 59 Seeks Approval 59 Announce Completion 58 Successful Completion 58 Provides Updates 58 Extends Tender Offer 58 Option Grants 58 Shows Promise 58 Announces Publication 58 Well Tolerated 58 RNAi Therapeutics 58 Blood Thinner 58 Discontinues 58 Announces Signing 58 Announces Non Brokered 58 Increases Risk 58 Smallpox Vaccine 58 Advanced Prostate Cancer 58 Reconfirms 58 Fourth Consecutive Year 58 Patent Infringement Case 58 Receives CE 58 Atopic Dermatitis 57 Licensing Deal 57 Subsidiary Receives 57 Achieves Record 57 k Clearance 57 Long Awaited 57 FDA Approval 57 Final Approval 57 Successfully Completes 57 Gets Approval 57 Announces Receipt 57 Patent Issued 57 Complete Merger 57 Attains 57 Completes Private Placement 57 Announces Commencement 57 Panel Backs 57 #.#/Share [002] 57 Updates Guidance 57 Hits Snag 57 Attains Gold Certified Partner 57 Stockholders Approve Merger 56 Acquire Assets 56 Nearing Completion 56 FDA Warns 56 Pivotal Trial

Back to home page